PICO Portalanswers from OpenAlex & ORCID
Jean MacFadyen
ResearcherPublications, citations & collaboration network
Jean MacFadyen is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Jean MacFadyen have?
PICO Portalindexed works
Jean MacFadyen has 88 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jean MacFadyen have?
PICO Portalcitation count
Jean MacFadyen has 37,551 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Jean MacFadyen?
PICO Portalh-index
Jean MacFadyen has an h-index of 56 in OpenAlex.
What is the i10-index of Jean MacFadyen?
PICO Portali10-index
Jean MacFadyen has an i10-index of 68 in OpenAlex.
What is the OpenAlex record for Jean MacFadyen?
PICO Portalopenalex
The OpenAlex for Jean MacFadyen is on the source record.
What are the most-cited papers on Jean MacFadyen?
PICO Portalmost cited works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker, Jean MacFadyen, Tom Thurén, Brendan M Everett, Peter Libby, Robert J. Glynn, Paul M. Ridker, Alberto Lorenzatti, Henry Krum, George Varigos, Peter Siostrzonek, Peter Sinnaeve, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Nina Gotcheva, Jacques Genest, Yong Huo, Miguel Urina‐Triana, Davor Miličić, Renata Cífková, Riina Vettus, Wolfgang Köenig, S.D. Anker, Athanasios Manolis, Fernando Wyss, Tamás Forster, Axel F. Sigurðsson, Prem Pais, Alessandro Fucili, Hisao Ogawa, Hiroaki Shimokawa, Irina Veze, Birutė Petrauskienė, Leon Salvador, John J.P. Kastelein, Jan H. Cornel, Tor Ole Klemsdal, Félix Medina, Andrzej Budaj, L Vida-Simiti, Zhanna Kobalava, Petar Otašević, Daniel Pella, Mitja Lainščak, Ki‐Bae Seung, Patrick Commerford, Mikael Dellborg, Marc Y. Donath, Juey‐Jen Hwang, Hakan Kültürsay, Marcus Flather, Christie M. Ballantyne, Seth Bilazarian, William H. Chang, Cara East, Brendan Everett, Les B. Forgosh, Robert J. Glynn, Barry Harris, Peter Libby, M Ligueros, Tom Thurén, Erin A. Bohula, Bindu Charmarthi, Susan Cheng, Sherry Chou, Jacqueline Suk Danik, Graham T. McMahon, Bradley A. Maron, MingMing Ning, Benjamin A. Olenchock, Reena L. Pande, Todd S. Perlstein, Aruna D. Pradhan, Natalia S. Rost, Aneesh B. Singhal, Viviany R. Taqueti, Nancy Wei, Howard A. Burris, Angela Cioffi, Anne Marie Dalseg, Nilanjan Ghosh, Julie R. Gralow, Tina Mayer, Hope S. Rugo, Vance G. Fowler, Ajit P. Limaye, Sara E. Cosgrove, Donald P. Levine, Renato D. Lópes, John Scott, Tom Thurén, M Ligueros, Robert Hilkert, Georgia Tamesby, Carolyn Mickel, Brian Manning, Julian Woelcke, Monique Tan, S Manfreda
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker, Brendan M. Everett, Aruna D. Pradhan, Jean MacFadyen, Daniel H. Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga, Milan Gupta, Michelle Tsigoulis, Subodh Verma, Michael Clearfield, Peter Libby, Samuel Z. Goldhaber, Roger L. Seagle, Cyril Ofori, Mohammad G. Saklayen, Samuel Butman, Narendra Singh, Michel Le May, Olivier F. Bertrand, James Johnston, Nina P. Paynter, Robert J. Glynn
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker, Jean MacFadyen, Brendan M Everett, Peter Libby, Tom Thurén, Robert J. Glynn, Paul M. Ridker, Jean MacFadyen, Brendan M Everett, Peter Libby, Tom Thurén, Robert J. Glynn, John J.P. Kastelein, Wolfgang Köenig, Jacques Genest, Alberto Lorenzatti, George Varigos, Peter Siostrzonek, Peter Sinnaeve, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Nina Gotcheva, Yong Huo, Miguel Urina‐Triana, Davor Miličić, Renata Cífková, Riina Vettus, S.D. Anker, Athanasios Manolis, Fernando Wyss, Tamás Forster, Axel F. Sigurðsson, Prem Pais, Alessandro Fucili, Hisao Ogawa, Hiroaki Shimokawa, Irina Veze, Birutė Petrauskienė, Leon Salvador, Jan H. Cornel, Tor Ole Klemsdal, Félix Medina, Andrzej Budaj, L Vida-Simiti, Zhanna Kobalava, Petar Otašević, Daniel Pella, Mitja Lainščak, Ki‐Bae Seung, Patrick Commerford, Mikael Dellborg, Marc Y. Donath, Juey‐Jen Hwang, Hakan Kültürsay, Marcus Flather, Christie M. Ballantyne, Seth Bilazarian, William H. Chang, Cara East, Les B. Forgosh, Barry Harris, M Ligueros
Adverse Effects of Low-Dose Methotrexate
Daniel H. Solomon, Robert J. Glynn, Elizabeth W. Karlson, Fengxin Lu, Cassandra Corrigan, Josh Colls, Chang Xu, Jean MacFadyen, Medha Barbhaiya, Nancy Berliner, Paul F. Dellaripa, Brendan M. Everett, Aruna D. Pradhan, Sarah P. Hammond, Meredith Murray, Deepak A. Rao, Susan Y. Ritter, Anna Rutherford, Jeffrey A. Sparks, Jackie Stratton, Dong Hyun Suh, Sara K. Tedeschi, Kathleen M.M. Vanni, Nina P. Paynter, Paul M. Ridker